Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 3, 1996, Pages 187-191

  Hare, C Bradley ^a   Elion, Gertrude B ^a   Houghton, Peter J ^b   Houghton, Janet A ^b   Keir, Stephen ^a   Marcelli, Susan L ^a   Bigner, Darell D ^c   Friedman, Henry S ^a,c  

^a DUKE UNIVERSITY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Camptothecin; CNS tumors; CPT 11; Topoisomerase I; Xenograft

Indexed keywords

BUSULFAN; CAMPTOTHECIN DERIVATIVE; CYCLOPHOSPHAMIDE; IRINOTECAN; MELPHALAN; PROCARBAZINE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG RESISTANCE; EPENDYMOMA; FEMALE; GLIOMA; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEDULLOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR XENOGRAFT;

EID: 0031060230     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050558     Document Type: Article

References (15)

1. Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS (1994) Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol 35:127
2. Boring CC, Squires TS, Tong T (1993) Cancer statistics, 1993. CA Cancer J Clin 43:7
3. Bullard DE, Bigner DD (1979) The heterotransplantation of human craniopharyngiomas in athymic "nude" mice. Neurosurgery 4:308
4. Dropcho EJ, Wisoff JH, Walker RW (1987) Surpatentorial malignant gliomas in childhood: a review of fifty cases. Ann Neurol 22:355
5. Friedman HS, Schold SC Jr, Varia M, Bigner DD (1983) Chemotherapy and radiation therapy of human medulloblastoma in athymic mice. Cancer Res 43:3088
6. Friedman HS, Colvin OM, Ludeman SM, Schold SC Jr, Boyd VL, Muhlbaier LH, Bigner DD (1986) Experimental chemotherapy of human medulloblastoma with classical alkylators. Cancer Res 46:2827
7. Friedman HS, Colvin OM, Skapek SX, Ludeman SM, Elion GB, Schold SC Jr, Jacobsen PF, Muhlbaier LH, Bigner DD (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48:4189
8. Friedman HS, Horowitz ME, Oakes WJ (1991) Tumors of the central nervous system. Improvement in outcome through a multi-modality approach. Pediatr Clin North Am 38:381
9. Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD (1991) Medulloblastoma: tumor biological and clinical perspectives. J Neurooncol 11:1
10. Friedman HS, Dolan ME, Moschel RC, Pegg AE, Felker GM, Rich J, Bigner DD, Schold SC Jr (1992) Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 84:1926
11. Friedman HS, Houghton PJ, Schold SC, Keir S, Bigner DD (1994) Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 34:171
12. Houghton PJ, Cheshire PJ, Hallman JD II, Lutz L, Friedman HS, Danks MK, Houghton JA (1995) Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother Pharmacol 36:393
13. Lilley ER, Elion GB, Dewhirst MW, Schold SC Jr, Blum MR, Savina PM, Laskowitz DT, Bigner DD, Friedman HS (1991) Therapeutic analysis of the melphalan-resistant human rabdomyosarcoma xenograft TE-671 MR. Cancer Res 51:3906
14. Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS (1989) Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49:6917
15. Slichenmeyer WJ, Rowinsky EK, Donehower RC, Kaufman SH (1993) The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 85:271